Co-Depricap Cap 3mg/25mg is a valuable pharmaceutical product that combines olanzapine and fluoxetine capsules USP to address symptoms associated with psychiatric disorders. Olanzapine is an antipsychotic medication that helps regulate the levels of certain neurotransmitters in the brain, thereby alleviating symptoms of psychosis, such as hallucinations and delusions. Fluoxetine, on the other hand, is a selective serotonin reuptake inhibitor (SSRI) that enhances the availability of serotonin in the brain, effectively treating symptoms of depression. By incorporating these two powerful ingredients, Co-Depricap Cap 3mg/25mg offers a multifaceted approach to mental health management. Olanzapine works by targeting the excess dopamine and serotonin activity, while fluoxetine provides further support by increasing serotonin levels.